Status:
UNKNOWN
Heart Failure in Norway: Clinical Characteristics, Mortality and Health Care Resource Use
Lead Sponsor:
University Hospital, Akershus
Collaborating Sponsors:
Novartis
Conditions:
Heart Failure
Heart Failure With Preserved Ejection Fraction
Eligibility:
All Genders
18+ years
Brief Summary
The prevalence of Heart failure above 70 years of age is 10% and 5 year mortality rate above 60%, higher than for cancer. The readmission rate first after hospitalisation is 44% despite the availabili...
Eligibility Criteria
Inclusion
- Diagnosis with ICD10 codes as follows; I50.\*, I42.3, I11.\* and COPD J44.\* from 2007 through 2019.
- In addition all subjects with NT-proBNP above age specific normal range in same period.
Exclusion
- none
Key Trial Info
Start Date :
January 20 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2023
Estimated Enrollment :
14998 Patients enrolled
Trial Details
Trial ID
NCT04398563
Start Date
January 20 2020
End Date
December 1 2023
Last Update
May 21 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Akershus University Hospital
Lørenskog, Norway